AlphaCognition
Alpha Cognition is a clinical stage, biopharmaceutical company developing treatments for neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis (ALS).
4
Funding Rounds
$12.3m
Money raised
Overview
Alpha Cognition is a clinical stage, biopharmaceutical company developing treatments for neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis (ALS).
- Website:
- Social accounts: linkedin
Industries
AlphaCognition is active in the following industries: